Mei Zhong Selected Research

fragile histidine triad protein

1/2008	Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
10/2006	Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
5/2006	[Expression of fragile histidine triad (FHIT) protein and its significance in diagnosing classical Hodgkin lymphoma].
10/2002	[Clinicopathological analysis of loss of fragile histidine triad expression in lung cancer].
4/2002	Loss of fragile histidine triad expression in colorectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei Zhong Research Topics

Disease

27	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2012
23	Neoplasms (Cancer) 10/2020 - 01/2002
8	Ovarian Neoplasms (Ovarian Cancer) 07/2019 - 06/2006
6	Infections 01/2020 - 12/2006
5	Inflammation (Inflammations) 01/2022 - 09/2015
5	Lymphatic Metastasis 01/2019 - 10/2002
5	Carcinoma (Carcinomatosis) 11/2012 - 01/2005
4	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2021 - 06/2011
4	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2008
4	Hodgkin Disease (Hodgkin's Disease) 06/2011 - 05/2006
3	Necrosis 01/2022 - 04/2005
3	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 07/2021 - 02/2003
3	Autistic Disorder (Autism) 01/2021 - 12/2014
3	Premature Birth (Birth, Premature) 01/2021 - 11/2017
3	Proteinuria 01/2020 - 01/2012
3	Thalassemia 06/2019 - 02/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 12/2006
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017 - 08/2014
3	Adenocarcinoma 07/2017 - 08/2009
3	Carcinogenesis 02/2015 - 01/2008
2	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Aneuploidy (Aneuploid) 01/2022 - 01/2010
2	Rupture 07/2021 - 09/2015
2	COVID-19 01/2021 - 01/2020
2	Seizures (Absence Seizure) 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 10/2020 - 10/2002
2	Congenital Abnormalities (Deformity) 03/2020 - 09/2017
2	Hemorrhage 01/2020 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 04/2002
2	Tuberculosis (Tuberculoses) 01/2018 - 07/2008
2	Preterm Premature Rupture of the Membranes 01/2017 - 09/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 10/2009
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2014 - 12/2004
2	Pregnancy Complications 10/2014 - 04/2012
2	Endometrial Neoplasms (Endometrial Cancer) 08/2014 - 05/2010
2	Breast Neoplasms (Breast Cancer) 08/2014 - 02/2008
1	Trisomy 18 Syndrome 01/2022
1	Trisomy 13 Syndrome 01/2022

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
6	Long Noncoding RNAIBA 01/2021 - 09/2015
5	CreatinineIBA 01/2020 - 01/2012
5	Biological ProductsIBA 01/2019 - 05/2008
5	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 12/2006
5	fragile histidine triad proteinIBA 01/2008 - 04/2002
5	Histidine (L-Histidine)FDA Link 01/2008 - 04/2002
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2009
4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 08/2009
4	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2010
4	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 01/2001
4	ParaffinIBA 12/2006 - 01/2002
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 06/2012
3	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
3	Advanced Oxidation Protein Products (AOPP)IBA 01/2021 - 01/2013
3	CytokinesIBA 01/2021 - 04/2005
3	CollagenIBA 01/2021 - 09/2015
3	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2012
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2015 - 06/2012
3	Uric Acid (Urate)IBA 01/2013 - 03/2012
3	Antithrombin IIIIBA 10/2009 - 01/2003
3	von Willebrand FactorIBA 01/2005 - 01/2003
3	Formaldehyde (Formol)FDA Link 10/2002 - 01/2002
2	Cyclophilin AIBA 01/2022 - 11/2020
2	arginine methyl esterIBA 01/2022 - 03/2021
2	Saline SolutionIBA 03/2021 - 12/2018
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 01/2015
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021 - 01/2019
2	Pentylenetetrazole (Metrazol)IBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 10/2020 - 08/2009
2	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 12/2016
2	NF-kappa B (NF-kB)IBA 01/2020 - 01/2010
2	Cell-Free Nucleic AcidsIBA 06/2019 - 12/2012
2	ORALIT (ORS)IBA 01/2019 - 08/2016
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 02/2015
2	Green Fluorescent ProteinsIBA 10/2017 - 03/2008
2	UbiquitinIBA 01/2017 - 09/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 09/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2016 - 08/2014
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2015 - 01/2015
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2014 - 01/2001
2	Cystatin CIBA 01/2013 - 07/2012
2	AlbuminsIBA 03/2012 - 01/2012
2	AntigensIBA 06/2011 - 01/2005
2	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2011 - 12/2008
2	Estrogens (Estrogen)FDA Link 05/2010 - 01/2001
2	PlasminogenIBA 02/2003 - 01/2003
2	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2003 - 01/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 02/2003 - 01/2003
2	Plasminogen InactivatorsIBA 02/2003 - 01/2003
2	Citric Acid (Citrate)FDA LinkGeneric 10/2002 - 04/2002
1	Amyloid (Amyloid Fibrils)IBA 01/2022

Therapy/Procedure

8	Therapeutics 01/2021 - 09/2006
4	Cesarean Section (Caesarean Section) 07/2021 - 04/2012
2	Injections 01/2021 - 06/2012
2	Transplantation 01/2020 - 03/2008
2	Lasers (Laser) 07/2019 - 04/2019
2	Cochlear Implantation 09/2017 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 11/2012
2	Neoadjuvant Therapy 01/2017 - 08/2014